Sent letter to Laura Forman, Investor Relations, this morning regarding my personal opinion of the poor performance of the extraordinary C-pulse and pointed out
the comparison of Intercept Pharmaceuticals who have developed or developing a kidney medication and whose share price went from $30 twelve months ago to a high of $445 and this morning is $375 and that of Sunshine Heart which
retreated another 37cents to $8.37.
There seems to be room for improvement...
- Forums
- ASX - By Stock
- SHC
- promotional of c-pulse
promotional of c-pulse, page-12
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)